When cannabis use becomes a clinical problem
Cannabis use disorder involves difficulty controlling cannabis use despite meaningful problems or unsuccessful efforts to reduce it. Assessment should consider frequency, potency, route, withdrawal, driving, school or work, relationships, pregnancy, other substances, and mental health rather than assuming all cannabis use has the same risk. The diagnosis is based on loss of control and consequences, not on whether cannabis is legal or medically authorized. A clinician should ask about attempts to cut down, time spent using, tolerance, withdrawal, and responsibilities that have been affected.
Behavioral treatment has the clearest support
No medication is currently approved by FDA specifically for cannabis use disorder. NIDA describes cognitive behavioral therapy, contingency management, and motivational enhancement therapy as behavioral approaches with evidence or promise, while research on medications continues. A quality program should name the therapy it uses and explain how sessions connect to the patient's goals. Medication may still be used for a separate condition, but it should not be advertised as an approved cure for cannabis use disorder.
Plan for sleep, mood, and cravings
Treatment may include goal setting, tracking use and triggers, coping and refusal skills, incentives for attendance or abstinence, sleep support, and therapy for co-occurring conditions. Withdrawal can include irritability, anxiety, sleep difficulty, reduced appetite, and cravings, and symptoms should be discussed with a clinician rather than treated with unverified products. The first days after reducing use can disrupt routines that were organized around cannabis. Tracking symptoms and keeping follow-up appointments helps the clinician distinguish expected withdrawal from a co-occurring condition that needs its own care.
Product type changes the risk discussion
Urgent evaluation is appropriate for severe panic, psychosis, suicidal thinking, dangerous behavior, chest pain, or suspected exposure to an unknown product. High-potency concentrates, synthetic cannabinoids, and cannabis mixed with alcohol or other drugs can create risks that differ from those of a known regulated product. Edibles can have delayed effects, concentrates may deliver high amounts of THC, and synthetic cannabinoids are a different category with unpredictable harms. Bring product labels or photographs when possible so the assessment is not based on the word cannabis alone.
Agree on outcomes before treatment starts
Ask whether the program has specific experience with cannabis use disorder, uses measurable goals, and can treat anxiety, depression, trauma, psychosis, or other substance use at the same time. Clarify whether the goal is abstinence, reduction, or another patient-centered outcome and how progress will be reviewed. Ask how attendance, use, cravings, sleep, driving, work, and mental health will be measured. If the initial goal is reduction, decide in advance which signs would lead the team to recommend abstinence or a more intensive level of care.
Make the home plan concrete
Start with a medical and behavioral health assessment, especially when attempts to stop have repeatedly failed or use affects safety and daily responsibilities. Remove easy access, plan for sleep and cravings, involve supportive people with consent, and schedule follow-up rather than relying on willpower alone. Remove stored products and paraphernalia with attention to children and pets, then replace usual use times with specific activities and support. Arrange a follow-up date before withdrawal or craving makes it easy to postpone the next decision.
Questions to bring to a cannabis treatment consultation
Ask how often the program treats cannabis use disorder and which behavioral methods its clinicians are trained to provide. Confirm how it evaluates psychosis, anxiety, depression, pregnancy, and use of alcohol or other drugs. Request a plan for withdrawal symptoms, sleep, and urgent changes in behavior. Finally, ask how the team will revise treatment if the chosen goal is not improving safety or daily functioning.